FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2014














































Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Secondary Progressive Multiple Sclerosis (SPMS). This report provides information on the therapeutic development based on the Secondary Progressive Multiple Sclerosis (SPMS) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Read more »

 

Parkinson's drug could prove to be new treatment for multiple sclerosis






















A drug used to treat Parkinson's disease may provide an effective new therapy for multiple sclerosis (MS), research suggests.
Read more »

 

Caesars Foundation Underwrites New Brain Health Initiative with Cleveland Clinic Lou Ruvo Center for Brain Health




















On the cusp of National Alzheimer’s Disease Awareness Month, Caesars Foundation is pleased to announce the beginning of a three-year commitment with an initial gift of $200,000 to benefit the Cleveland Clinic Lou Ruvo Center for Brain Health, a state-of-the-art center with cutting edge clinical trials and treatment for conditions like Alzheimer’s, Multiple Sclerosis and Parkinson’s disease located in Las Vegas, Nevada. Caesars Foundation serves as the sole funder of the HealthyBrains initiative.
Read more »

 

Vitamin D and Exercise

















































Nina Laidlaw Rumler, B.A.

This article is by Ms. Nina Laidlaw Rumler, and discusses how Vitamin D consumption affects exercise, and health as a whole. Take it away, Nina!
Read more »

Labels: ,


 

Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study: STUDY

Saturday

 

Leaders hear pitch for proposed wellness center to help wounded warriors





































Shawn Conaway braced himself on one chair, then another.

Then the former Army staff sergeant eased himself out of his motorized wheelchair and, in a room of strangers, stood to applause.
Read more »

 

Researchers at the Doorstep of Stem Cell Therapies for MS, Other Myelin Disorders
















































When the era of regenerative medicine dawned more than three decades ago, the potential to replenish populations of cells destroyed by disease was seen by many as the next medical revolution. However, what followed turned out not to be a sprint to the clinic, but rather a long tedious slog carried out in labs across the globe required to master the complexity of stem cells and then pair their capabilities and attributes with specific diseases.
Read more »

Labels:


 

A “Fatigue” Disorder No More? – What Multiple Sclerosis Taught Us About Fatigue and Chronic Fatigue Syndrome



























The “Fatigue” Disorders

Multiple sclerosis (MS) ranks amongst the most fatiguing disorders known.  The most common symptom found in MS (75-95% of patients), fatigue is a major research topic with ten studies in the last five months featuring fatigue in their titles.
Read more »

Labels:


 

Lawbreaker: MULTIPLE SCLEROSIS GOES CRIMINAL (by Yvonne deSousa)


When I typed the title of this blog post I was saying to myself, laaaaaawwwww breaker, using a Matthew McConaughey legal thriller voice.   What does Matthew’s southern accent have to do with this blog?
Read more »

Labels:


 

Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up: STUDY

Friday

 

Improving Reproductive and Sexual Health Outcomes in Women with Multiple Sclerosis: VIDEO




















Strategies for Enhancing Patient-Provider Communications presented at the 2014 Women’s Health Annual Visit® Series Jointly developed by Athena Education Group and Omnia Education.
Story Source: The above story is based on materials provided by HEALTH-FUL-HINTS
Note: Materials may be edited for content and length

Labels:


 

Parkinson's drug could prove to be new treatment for multiple sclerosis


































Early tests show that benztropine stimulates the production of nerve-repairing cells and helped eliminate MS relapses
Read more »

 

Our Corporate Masters Are Poisoning Us And Making Us Sick– For Quick Profits






























Let me take a break from the election for a minute– at least in terms of politicians. There were also food policy issues on the ballot around the country. The results were mixed.
Read more »

Labels:


 

Helping those living with Multiple Sclerosis


















There are more than 8,000 people in Indiana living with Multiple Sclerosis.  Skytrak 13 Meteorologist Nicole Misencik is in Fort Worth, Texas, taking part in a Multiple Sclerosis Society's Leadership Conference.
Read more »

Labels:


 

Categorical change in T2 lesion volume and clinical outcomes in the Phase III FREEDOMS and its extension study, evaluating Gilenya (fingolimod) in patients with relapsing-remitting multiple sclerosis: STUDY

Thursday

 

Impact of MS during the critical window of brain development



































In this issue of Neurology®, Aubert-Broche et al.1 study the longitudinal change in brain volume in 36 children with multiple sclerosis (MS) (mean age at scan 13.77 years) compared to 25 local healthy children and 339 healthy children from an NIH-sponsored database.
Read more »

Labels:


 

Police won't charge woman in service dog incident


























Northern Illinois University police have identified the woman who allegedly kicked a service dog last month but have decided not to charge her.
Read more »

 

Generic Glatiramer, Cannabis Product Advance for MS

























A lower-cost version of one of the mainstays of first-line multiple sclerosis treatment appears poised to win marketing approval on the basis of pivotal trial results, and the marijuana derivative known as Sativex was, for the first time, shown to improve an objective measure of spasticity in a randomized trial. The studies were presented recently at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held jointly this year with its North American counterpart, ACTRIMS.
Read more »

Labels: , ,


 

Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
































Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Active Biotech (NASDAQ OMX NORDIC:ACTI) today announced the expansion of the laquinimod clinical development program with the initiation of the ARPEGGIO trial, which will evaluate the potential of laquinimod to treat primary progressive multiple sclerosis (PPMS). Additionally, Teva has screened the first patient in the LEGATO-HD trial, which will evaluate laquinimod in Huntington's disease. Currently, there are no approved therapies available for the treatment of PPMS or the treatment of Huntington's disease, beyond symptom management.
Read more »

Labels:


 

Cost-effectiveness of subcutaneous interferon beta-1a in a sub-population of multiple sclerosis patients (Kurtzke Expanded Disability Status Scale [EDSS] .3.5–5.0): STUDY

Wednesday

 

Multiple Sclerosis project targets earlier detection
























Albertans with multiple sclerosis are hoping a research project at the University of Alberta will lead to earlier detection and better treatment of the disease.
Read more »

 

Mom joining MS fitness program started by son























MSFit will soon offer free exercise classes at the Gateway YWCA to help those with multiple sclerosis improve their lives.
Read more »

 

Poole Hospital carries out ground-breaking neurological research trials


























Sacha Crowley, Annemieke Fox, Angela Schofield, David Higenbottham, Lynette Crawley
Read more »

 

Genzyme enrolls first patient in Phase II vatelizumab trial in RRMS patients




























Sanofi's Genzyme has started enrolling patients in a multicenter Phase II clinical trial (EMPIRE) of its investigational infusion therapy vatelizumab in patients with relapsing remitting multiple sclerosis (RRMS).
Read more »

Labels:


 

Seroprevalence of Aquaporin-4–IgG in a Northern California Population Representative Cohort of Multiple Sclerosis: STUDY

Tuesday

 

Collaborative Penn-Dresden Study Blocks Multiple Sclerosis Relapses in Mice
























In multiple sclerosis, the immune system goes rogue, improperly attacking the body’s own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
Read more »

 

The Emotional Side Of MS: Understanding Pseudobublar Affect (PBA)



























If you find yourself crying or laughing uncontrollably, you are not alone. Although most people have never heard of pseudobulbar affect (PBA), it’s estimated that two million Americans are suffering from this neurologic condition. Ten percent of these are people living with multiple sclerosis (MS).
Read more »

 

David Osmond finds strength in MS fight through music



























From left to right, Alan Osmond, singer David Osmond, and singer Donny Osmond arrive at the National Multiple Sclerosis Society's Dinner of Champions benefit gala in Los Angeles on Monday, Sept. 27, 2010. (AP Photo/Dan Steinberg)
Read more »

 

Penn-Dresden study blocks multiple sclerosis relapses in mice: STUDY

















































In multiple sclerosis, the immune system goes rogue, improperly attacking the body's own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
Read more »

Labels:


 

Epstein-Barr virus candidate genes and multiple sclerosis: STUDY

Monday

 

Want to Give Back? Take This New MS Survey































The longer we live with MS, the more we have to give back to our community.  That said, the longer I live with multiple sclerosis, the harder it seems to remember the time before MS.  A new survey on MS posted by Everyday Health made me bounce back and forth from my early teen years to the present.
Read more »

 

Virginia Youth Group Earns International Youth Philanthropy Award





























Members of the Miles of Scarves organization gather weekly to knit scarves to benefit the Multiple Sclerosis Society.
Read more »

 

MS and Parkinson’s research trials undertaken at Poole Hospital






















CRUCIAL clinical research is being carried out at Poole Hospital into the causes and treatments of a range of neurological conditions.
Read more »

 

How obesity triggers auto-immune diseases






















A new study points to the major role obesity plays in triggering and prolonging auto-immune diseases.
Read more »

Labels:


 

Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes: STUDY

Sunday

 

Lives will be lost unless the Government acts on off-patent drugs, charities warn






























Jonathan Evans

Leading medical charities have warned “lives could be lost” if the Government does not act to make a group of low-cost, safe drugs for conditions including breast cancer, multiple sclerosis (MS) and Parkinson’s available to patients.
Read more »

 

Perth Divinyls tribute singer diagnosed with multiple sclerosis






















Donna Greene was in her element, rocking out on stage at a Divinyls tribute act. A photographer snapped a picture as the band hit a crescendo in the song, but at that moment, Mrs Greene knew something was very wrong.
Read more »

 

Medical marijuana inquiry calls for public submissions on draft legislation






















An ACT Legislative Assembly committee conducting an inquiry into the use of medical cannabis in the community has called for public submissions.
Read more »

Labels:


 

Classic Seven Layer Cookie Bars



















































Classic Seven Layer Cookie Bars
Read more »

 

Does interferon beta therapy affect survival of multiple sclerosis patients?

Saturday

 

Natural Remedy For Depression

 

David Osmond raises awareness for Multiple Sclerosis


























David Osmond kicked off the opening ceremony at the Walk MS: Houston event on Sunday, Nov. 10. For David, the fundraising event for the National Multiple Sclerosis Society was part of his personal mission to bring more awareness to MS diagnosis and treatment. Both he and his father, Alan, have been diagnosed with MS.
Read more »

Labels:


 

Jail policy on medication disposal criticized









































A northwestern Indiana jail is under fire for the way it handles inmates' prescription drugs.
Read more »

 

Living well with multiple sclerosis
















































THIS BOOK includes personal narratives of 12 individuals with multiple sclerosis (MS) who have made intensive lifestyle changes with significant benefits.
Click here to read original article

 

Fear of Disease Progression in Patients with Multiple Sclerosis: Associations of Anxiety, Depression, Quality of Life, Social Support and Knowledge: STUDY

Friday

 

‘Breaking Bad’ spoof video raises awareness for multiple sclerosis: VIDEO
























The scene is shot from a rooftop parking lot in Downtown Albuquerque, the Sandia Mountains visible in the distance.
Read more »

Labels:


 

Ned Norton: Fitness buff helps disabled find 'strength'


























Ned Norton was working as a fitness trainer for Olympic athletes and bodybuilders when a young man with a spinal cord injury asked him for help.
Read more »

Labels:


 

Understanding Myelin in Multiple Sclerosis


























A better understanding of myelin and how it works (or doesn’t work) can be helpful when reading about research and studies of MS and the potential impact they may have on the disease. That’s one reason why a new report about myelin from a team of scientists at the Cambridge Stem Cell Institute is of interest.
Read more »

 

Drugs farce shows up meddling politicians























The Cancer Drugs Fund was as much a creation of political necessity as it was medical. This was never more obvious than last week, when it was announced that up to half the drugs it currently makes available are likely to be removed from its list because they are deemed too expensive.
Read more »

 

Sex Hormones and Immune Dimorphism: STUDY


Go to Newer News Go to Older News